BSH 2023 | PETReA: evaluating PET-adapted maintenance therapy approaches for patients with follicular lymphoma

  • Kim Linton

Press/Media: Research

Description

Video describing the PETReA Trial 

Period24 Apr 2023

Media coverage

1

Media coverage

  • TitleBSH 2023 | PETReA: evaluating PET-adapted maintenance therapy approaches for patients with follicular lymphoma
    Degree of recognitionInternational
    Media name/outletVJHaemOnc
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date24/04/23
    DescriptionIn this video, Kim Linton, MBChB, MRCP, PhD, FRCP, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK, offers insight into the NCRI-led randomized Phase III PETReA study (CRUK/16/017), evaluating PET-adapted maintenance therapy approaches in patients with newly diagnosed follicular lymphoma (FL). Dr Linton also discusses a further arm of the PETReA study aimed at improving maintenance therapy with lenalidomide in patients who do not achieve a complete response. To conclude, Dr Linton notes further sub-studies within PETReA, including efforts to address responses to COVID-19 vaccination. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
    Producer/AuthorVJHaemOnc
    URLhttps://www.vjhemonc.com/video/0lsyhxbckma-petrea-evaluating-pet-adapted-maintenance-therapy-approaches-for-patients-with-follicular-lymphoma/
    PersonsKim Linton

Conference

Title63rd British Society of Haematology Annual Scientific Meeting
Location, Birmingham, United Kingdom
Period23 Apr 2023 → 25 Apr 2023